# CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes

> **NCT06788379** · — · RECRUITING · sponsor: **Vida Recoletas Sevilla** · enrollment: 160 (estimated)

## Conditions studied

- Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes
- Advance Maternal Age
- Vitrification and Thawing

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06788379
- **Lead sponsor:** Vida Recoletas Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788379, "CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06788379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*